160 related articles for article (PubMed ID: 10101717)
1. Filarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status.
Nicolas L; Langy S; Plichart C; Deparis X
Parasite Immunol; 1999 Feb; 21(2):73-80. PubMed ID: 10101717
[TBL] [Abstract][Full Text] [Related]
2. The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.
Petersen HH; Nielsen NO; Monrad J; Magesa SM; Simonsen PE
Parasitol Int; 2009 Jun; 58(2):141-4. PubMed ID: 19567236
[TBL] [Abstract][Full Text] [Related]
3. Assessing drivers of the IgG4 antibody reactivity to recombinant antigen Bm14 in Wuchereria bancrofti endemic populations in East Africa.
Damgaard J; Meyrowitsch DW; Rwegoshora RT; Magesa SM; Mukoko DA; Simonsen PE
Acta Trop; 2016 Sep; 161():26-32. PubMed ID: 27172877
[TBL] [Abstract][Full Text] [Related]
4. Filarial-specific IgG4 response correlates with active Wuchereria bancrofti infection.
Kwan-Lim GE; Forsyth KP; Maizels RM
J Immunol; 1990 Dec; 145(12):4298-305. PubMed ID: 2258618
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to a filarial antigen fraction in individuals exposed to Wuchereria bancrofti infection in India.
Bal M; Das MK
Acta Trop; 1999 Apr; 72(3):259-74. PubMed ID: 10232782
[TBL] [Abstract][Full Text] [Related]
7. Bancroftian filariasis in Tanzania: specific antibody responses in relation to long-term observations on microfilaremia.
Simonsen PE; Meyrowitsch DW
Am J Trop Med Hyg; 1998 Nov; 59(5):667-72. PubMed ID: 9840579
[TBL] [Abstract][Full Text] [Related]
8. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
[TBL] [Abstract][Full Text] [Related]
9. Microfilaraemia, filarial antibody, antigen and immune complex levels in human filariasis before, during and after DEC therapy. A two-year follow-up.
Ramaprasad P; Prasad GB; Harinath BC
Acta Trop; 1988 Sep; 45(3):245-55. PubMed ID: 2903626
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.
Weil GJ; Lammie PJ; Richards FO; Eberhard ML
J Infect Dis; 1991 Oct; 164(4):814-6. PubMed ID: 1894943
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic filariasis-specific immune responses in relation to lymphoedema grade and infection status. II. Humoral responses.
Nielsen NO; Bloch P; Simonsen PE
Trans R Soc Trop Med Hyg; 2002; 96(4):453-8. PubMed ID: 12497987
[TBL] [Abstract][Full Text] [Related]
12. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
[TBL] [Abstract][Full Text] [Related]
13. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
[TBL] [Abstract][Full Text] [Related]
14. Bancroftian filariasis in Kwale District of Kenya. II. Humoral immune responses to filarial antigens in selected individuals from an endemic community.
Estambale BB; Simonsen PE; Vennervald BJ; Knight R; Bwayo JJ
Ann Trop Med Parasitol; 1994 Apr; 88(2):153-61. PubMed ID: 8067811
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of circulating human IgG4 after diethylcarbamazine and ivermectin treatment of bancroftian filariasis.
Wamae CN; Roberts JM; Eberhard ML; Lammie PJ
J Infect Dis; 1992 Jun; 165(6):1158-60. PubMed ID: 1583340
[TBL] [Abstract][Full Text] [Related]
16. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin.
Eberhard ML; Hightower AW; Addiss DG; Lammie PJ
Am J Trop Med Hyg; 1997 Oct; 57(4):483-6. PubMed ID: 9347968
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.
Nicolas L; Plichart C; Nguyen LN; Moulia-Pelat JP
J Infect Dis; 1997 Feb; 175(2):489-92. PubMed ID: 9203681
[TBL] [Abstract][Full Text] [Related]
18. The immunodominant Brugia malayi paramyosin as a marker of current infection with Wuchereria bancrofti adult worms.
Langy S; Plichart C; Luquiaud P; Williams SA; Nicolas L
Infect Immun; 1998 Jun; 66(6):2854-8. PubMed ID: 9596759
[TBL] [Abstract][Full Text] [Related]
19. Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti.
Arndts K; Deininger S; Specht S; Klarmann U; Mand S; Adjobimey T; Debrah AY; Batsa L; Kwarteng A; Epp C; Taylor M; Adjei O; Layland LE; Hoerauf A
PLoS Negl Trop Dis; 2012; 6(4):e1611. PubMed ID: 22509424
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of filarial antigens in jirds and patients after treatment.
Zheng HJ; Tao ZH; Cheng WF; Zhang SM; Chen X; Fang RL; Xu M; Fuhrmen JA; Piessens WF
Chin Med J (Engl); 1991 Jul; 104(7):531-8. PubMed ID: 1879215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
